{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:16:31Z","timestamp":1784891791871,"version":"3.55.0"},"reference-count":38,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570342"],"award-info":[{"award-number":["81570342"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81600298"],"award-info":[{"award-number":["81600298"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY14H310011"],"award-info":[{"award-number":["LY14H310011"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["Y2100551"],"award-info":[{"award-number":["Y2100551"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007194","name":"Wenzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["Y20130038"],"award-info":[{"award-number":["Y20130038"]}],"id":[{"id":"10.13039\/501100007194","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2016.00408","type":"journal-article","created":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T07:09:06Z","timestamp":1477984146000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["The Protective Effects of Ivabradine in Preventing Progression from Viral Myocarditis to Dilated Cardiomyopathy"],"prefix":"10.3389","volume":"7","author":[{"given":"Li","family":"Yue-Chun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Guang-Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Li-Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Xinqiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Xiao-Ya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xiangjun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,11,1]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/ncb826","article-title":"Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta.","volume":"4","author":"Abreu","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1161\/HYPERTENSIONAHA.111.183913","article-title":"Role of heart rate reduction in the prevention of experimental heart failure: comparison between If-channel blockade and beta-receptor blockade.","volume":"59","author":"Becher","year":"2012","journal-title":"Hypertension"},{"key":"B3","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1126\/science.6484569","article-title":"Retarding effect of lowered heart rate on coronary atherosclerosis.","volume":"226","author":"Beere","year":"1984","journal-title":"Science"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1161\/01.ATV.12.11.1245","article-title":"Experimental atherosclerosis at the carotid bifurcation of the cynomolgus monkey: localization, compensatory enlargement, and the sparing effect of lowered heart rate.","volume":"12","author":"Beere","year":"1992","journal-title":"Arterioscler. Thromb."},{"issue":"7","key":"B5","doi-asserted-by":"publisher","DOI":"10.1186\/1755-1536-2-7","article-title":"Focus on collagen: in vitro systems to study fibrogenesis and antifibrosis state of the art.","volume":"2","author":"Chen","year":"2009","journal-title":"Fibrogenesis Tissue Repair"},{"key":"B6","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1161\/01.RES.0000241053.89089.c3","article-title":"Inflame my heart (by p38-MAPK).","volume":"99","author":"Clerk","year":"2006","journal-title":"Circ. Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0735-1097(99)00630-0","article-title":"Cardiac remodeling\u2013concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling.","volume":"35","author":"Cohn","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1161\/CIRCULATIONAHA.107.746537","article-title":"Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.","volume":"117","author":"Custodis","year":"2008","journal-title":"Circulation"},{"key":"B9","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ijcard.2012.04.076","article-title":"Anti-inflammatory effects of ivabradine in patients with acute coronary syndrome: a pilot study.","volume":"158","author":"Dominguez-Rodriguez","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1161\/01.CIR.0000043802.38699.66","article-title":"Interleukin-6-deficient mice resist development of autoimmune myocarditis associated with impaired upregulation of complement C3.","volume":"107","author":"Eriksson","year":"2003","journal-title":"Circulation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/S0002-9440(10)63241-5","article-title":"Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart.","volume":"165","author":"Fairweather","year":"2004","journal-title":"Am. J. Pathol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0140-6736(08)61171-X","article-title":"Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial.","volume":"372","author":"Fox","year":"2008","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1006\/jmcc.2001.1416","article-title":"Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice.","volume":"33","author":"Gluck","year":"2001","journal-title":"J. Mol. Cell Cardiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0042-6822(03)00538-5","article-title":"Direct interferon-gamma-mediated protection caused by a recombinant coxsackievirus B3.","volume":"315","author":"Henke","year":"2003","journal-title":"Virology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1038\/sj.bjp.0707673","article-title":"Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents.","volume":"153","author":"Heusch","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1161\/01.CIR.0000165117.71483.0C","article-title":"p38 MAP kinase mediates inflammatory cytokine induction in cardiomyocytes and extracellular matrix remodeling in heart.","volume":"111","author":"Li","year":"2005","journal-title":"Circulation"},{"key":"B17","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.bbrc.2012.12.147","article-title":"Ivabradine inhibits the production of proinflammatory cytokines and inducible nitric oxide synthase in acute coxsackievirus B3-induced myocarditis.","volume":"431","author":"Li","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B18","doi-asserted-by":"publisher","first-page":"12283","DOI":"10.1073\/pnas.211086598","article-title":"The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy.","volume":"98","author":"Liao","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"15895","key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/srep15895","article-title":"Dose-dependent protective effect of nicotine in a murine model of viral myocarditis induced by coxsackievirus B3.","volume":"5","author":"Li-Sha","year":"2015","journal-title":"Sci. Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.lfs.2016.02.003","article-title":"Nicotine inhibits the production of proinflammatory cytokines of mice infected with coxsackievirus B3.","volume":"2016","author":"Li-Sha","year":"2016","journal-title":"Life Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s11095-005-9043-5","article-title":"Smad3 specific inhibitor, naringenin, decreases the expression of extracellular matrix induced by TGF-beta1 in cultured rat hepatic stellate cells.","volume":"23","author":"Liu","year":"2006","journal-title":"Pharm. Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.biocel.2003.12.003","article-title":"Tissue repair and the dynamics of the extracellular matrix.","volume":"36","author":"Midwood","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1161\/01.CIR.0000118464.48959.1C","article-title":"Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.","volume":"109","author":"Mulder","year":"2004","journal-title":"Circulation"},{"key":"B24","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1093\/eurheartj\/ehs396","article-title":"Evidence of a synergistic association between heart rate, inflammation, and cardiovascular mortality in patients undergoing coronary angiography.","volume":"34","author":"O Hartaigh","year":"2013","journal-title":"Eur. Heart J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1161\/01.CIR.98.2.149","article-title":"Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling.","volume":"98","author":"Ono","year":"1998","journal-title":"Circulation"},{"key":"B26","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S0002-9149(01)01683-6","article-title":"Precipitating factors and decision-making processes of short-term worsening heart failure despite \u201coptimal\u201d treatment (from the IN-CHF registry).","volume":"88","author":"Opasich","year":"2001","journal-title":"Am. J. Cardiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.pcad.2009.05.003","article-title":"Heart rate as a risk factor for cardiovascular disease.","volume":"52","author":"Perret-Guillaume","year":"2009","journal-title":"Prog. Cardiovasc. Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.tcm.2003.11.002","article-title":"Stress-activated MAP kinases in cardiac remodeling and heart failure; new insights from transgenic studies.","volume":"14","author":"Petrich","year":"2004","journal-title":"Trends Cardiovasc. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3109\/07853899708999358","article-title":"Cytokines and cardiomyocyte death.","volume":"29","author":"Pulkki","year":"1997","journal-title":"Ann. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ejphar.2009.12.019","article-title":"Left ventricular enlargement in coxsackievirus-B3 induced chronic myocarditis\u2013ongoing inflammation and an imbalance of the matrix degrading system.","volume":"630","author":"Rutschow","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.ehj.2003.12.003","article-title":"Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease.","volume":"25","author":"Sajadieh","year":"2004","journal-title":"Eur. Heart J."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1161\/CIRCRESAHA.109.213199","article-title":"MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart.","volume":"106","author":"Streicher","year":"2010","journal-title":"Circ. Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"B34","doi-asserted-by":"publisher","first-page":"H911","DOI":"10.1152\/ajpheart.00124.2009","article-title":"Dominant-negative p38alpha mitogen-activated protein kinase prevents cardiac apoptosis and remodeling after streptozotocin-induced diabetes mellitus.","volume":"297","author":"Thandavarayan","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"751313","key":"B35","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/751313","article-title":"Ivabradine reduces chemokine-induced CD4-positive lymphocyte migration.","volume":"2010","author":"Walcher","year":"2010","journal-title":"Mediators Inflamm."},{"key":"B36","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1006\/jmcc.1994.1036","article-title":"Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms.","volume":"26","author":"Weber","year":"1994","journal-title":"J. Mol. Cell Cardiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.yjmcc.2009.08.019","article-title":"Immunomodulation and matrix metalloproteinases in viral myocarditis.","volume":"48","author":"Westermann","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"e39394","key":"B38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039394","article-title":"Comparison of effects of ivabradine versus carvedilol in murine model with the Coxsackievirus B3-induced viral myocarditis.","volume":"7","author":"Yue-Chun","year":"2012","journal-title":"PLoS ONE"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2016.00408\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T01:38:46Z","timestamp":1568511526000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2016.00408\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,1]]},"references-count":38,"URL":"https:\/\/doi.org\/10.3389\/fphar.2016.00408","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,1]]}}}